SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital ...

Sophia Genetics has launched an artificial-intelligence-powered tool that creates virtual copies of patients, known as ...

AI in biotechnology is rapidly transforming genetic engineering, personalized medicine, and drug discovery by enabling faster ...

A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology ...

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2025 before U.S. markets open on Tuesday, ...

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an ...

A clinically validated screening tool, now redesigned for parents with AI support and instant results at home. ATLANTA, Aug. 25, 2025 /PRNewswire/ -- Neo Sophia today announced the launch of Screener, ...

The AI-powered shopping assistant has become one of 2025’s buzziest launches, not only for its vision of how Gen Z shops, but also for the powerhouse founders leading it: Phoebe Gates and Sophia ...

SOPHiA GENETICS introduces AI-powered Digital Twins to enhance intelligent decision-making in oncology: Boston Saturday, October 18, 2025, 17:00 Hrs [IST] SOPHiA GENETICS, a leade ...